Trials / Completed
CompletedNCT00821002
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)
An Open-Label, Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Mati Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Latanoprost | Comparison of punctal plug placement between upper and lower puncta |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2009-01-12
- Last updated
- 2013-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00821002. Inclusion in this directory is not an endorsement.